DalsnaFinance › IPOs › Arcus Biosciences, Inc.
Arcus Biosciences, Inc. completed its initial public offering on NYSE on March 15, 2018, pricing at $15.00 a share.
| Ticker | RCUS |
|---|---|
| Exchange | NYSE |
| Status | Completed |
| Listing date | March 15, 2018 |
| Offering price | $15.00 |
| Shares offered | 8,000,000 |
| Total raised | $120M |
Arcus Biosciences, Inc. — quote, profile and latest news →
IPO data is compiled from SEC filings. This page is general information, not investment advice.